The Biotech Rebound Is Just Beginning
Health care and biotech stocks are poised to take off in the years to come, thanks to new technologies and medicines......»»
The Week Ahead In Biotech: Regeneron, Supernus FDA Decisions, Cancer Conference Presentations In The Spotlight
Biotech stocks ended the holiday-shortened week ended April 1 in the green, catalyzed by the broader market rebound and a slew of company-specific news flow. Buoyed by hopes of a U.S. read more.....»»
Apple Plans To Delay iPhone Production Ramp, Will Produce 20% Fewer Units
Apple Plans To Delay iPhone Production Ramp, Will Produce 20% Fewer Units A little over a week ago, as global stocks were just beginning a rebound that woul.....»»
Inovio to Begin Testing COVID-19 Vaccine
Biotech firm Inovio has begun Phase 1 trials of a new vaccine for COVID-19. The trial is beginning Monday......»»
Boeing 737 MAX supplier UTC not expecting more production cuts in 2019
UTC's outlook and other MAX news had shares of both Boeing Co. and Wichita's Spirit AeroSystems Inc. beginning to rebound on Tuesday......»»
Dollar up, stocks fall after Fed cut; pound rebound stalls
The dollar index rose on Wednesday and stocks tumbled even as the Federal Reserve cut interest rates after Fed Chairman Jerome Powell said the 25-basis-point cut was not the same as the beginning of a lengthy rate cutting cycle......»»
South Florida biotech raises $56M in Series A funding
Another South Florida health care startup has raised a significant round of funding as venture capital investments rebound in the region. X-Vax Technology, a biotechnology firm based in Jupiter, has raised $56 million in upsized Series A financing.....»»
The Week Ahead In Biotech: Conferences, Clinical Trial Readouts And Earnings
Biotech stocks saw muted sentiment in the holiday-shortened week ending July 5 after a strong rebound in the later part of the previous week. Activity was light, although news on clinical trial readouts continued to flow. read more.....»»
Biotech advances changing surgical possibilities
Beginning in April, Erie County Medical Center surgeons will be able to offer a new option: a surgically implanted device that uses neurostimulation therapy to treat sleep apnea......»»
Is Gilead Sciences, Inc. (GILD) a Buy?
The big biotech could be ready for a big rebound......»»
New life for failed drugs? A biotech veteran’s new startup sees a path to FDA approval.
The Maryland company is raising $2 million for key hires — and that's just the beginning......»»
Why Dillard"s Latest Recovery Isn"t Here to Stay
Like its larger peers Macy s 160 and Kohl s Dillard s NYSE DDS experienced a rebound in sales and earnings growth beginning in late 2017 Comps rose 3 in the fourth quarter of fiscal 2017 and 2 the next quarter In this Industry Focus 160 video.....»»
The Week Ahead: Pharma IPOs Galore, Blackberry Earnings And More
Below is a list of notable corporate events for the week beginning June 18. Note, this list is not comprehensive and all dates are subject to change. All times are ET. Monday Conferences Blockchain Economic Forum June 16-19 FDA/Biotech Latest Rat.....»»
The 3 Worst Biotech Stocks of 2018 (So Far)
These biotech stocks have taken a beating this year. But are any of them ready to rebound?.....»»
Smaller-size TV panel prices to pick up further in August
After suffering a major tumble in the second quarter of 2018, the quotes for smaller-size TV panels are beginning to rebound in July, likely to pick up furt.....»»
Why the Harley Davidson Stock Rebound Is Just Beginning
InvestorPlace - Stock Market News, Stock Advice & Trading Tips HOG stock has been one of 2018's bi.....»»
Global Stocks Rebound After Steep Selloff
Global stocks rebounded, calming jittery investors who had been weighing whether this week’s deep selloff was the beginning of a broader downturn or simply a two-day blip......»»
Global Stocks Regain Ground After Selloff
Global stocks gained and U.S. indexes looked set to rebound, calming jittery investors who had been weighing whether this week’s deep selloff was the beginning of a broader downturn or simply a two-day blip......»»
The Week Ahead In Biotech: ESMO Conference, PDUFA Dates, Clinical Trial Results, Large-Cap Pharma Earnings And IPOs
Biotech stocks are staging a rebound following the losses incurred in the week ended Oct. 12 amid catalysts that include the third-quarter earnings s.....»»